| Literature DB >> 33815592 |
Dragos Serban1,2, Bogdan Socea1,3, Cristinel Dumitru Badiu1,4, Corneliu Tudor2, Simona Andreea Balasescu2, Dan Dumitrescu1,2, Andra Maria Trotea1,5, Radu Iulian Spataru1,6, Geta Vancea1,7, Ana Maria Dascalu1, Ciprian Tanasescu8.
Abstract
The present study investigated the effects of the COVID-19 pandemic on the clinical presentation and therapeutic management of acute surgical abdomen. A retrospective study of emergency hospitalizations with a diagnosis of acute surgical abdomen between April and July 2020 vs. a similar period in 2019 was performed. The observation sheets and the operating protocols were analyzed. Between April and July 2020, 50 cases of acute surgical abdomen were hospitalized and treated, compared to 43 cases in the same period last year. The main types of pathology in both groups included: Occlusions (60%, respectively 44.2% in 2019) and peritonitis (32%, respectively 41.8% in 2019). There was an increased rate of patients with colorectal cancers neglected therapeutically or uninvestigated, who presented during the pandemic period with emergencies for complications such as occlusion or tumor perforation (32 vs. 6.97%, P=0.0039). One case, with gastric perforation, was COVID-positive, with no pulmonary symptoms at admission. The number of postoperative infectious complications was lower during the pandemic (2 vs. 13.95%, P=0.0461). As the COVID-19 pandemic appears to be still far from ending, we should learn to adapt our surgical protocols to the new evidence. Oncological patients are a vulnerable group, who were neglected in the first months of the pandemic. SARS-Cov-2 infection may be a cause of abdominal pain and should be taken into account in different diagnoses of acute abdomen in surgical wards. Correct wearing of adequate personal protective equipment (PPE) and respecting strict rules of asepsis and antisepsis are required for preventing in-hospital transmission of infection.Entities:
Keywords: COVID-19 pandemic; acute abdomen; emergency surgery; oncological
Year: 2021 PMID: 33815592 PMCID: PMC8014977 DOI: 10.3892/etm.2021.9950
Source DB: PubMed Journal: Exp Ther Med ISSN: 1792-0981 Impact factor: 2.447